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Abstract
Objective: Even though much progress has been made in defining primitive hematologic cell phenotypes by 
using flow cytometry and clonogenic methods, the direct method for study of marrow repopulating cells still 
remains to be elusive. Long Term Culture-Initiating Cells (LTC-IC) are known as the most primitive human 
hematopoietic cells detectable by in vitro functional assays. 
Materials and Methods: In this study, LTC-IC with limiting dilution assay was used to evaluate repopulating 
potential of cord blood stem cells. 
Results: CD34 selections from cord blood were completed succesfully with magnetic beads (73,64%±9,12). 
The average incidence of week 5 LTC-IC was 1: 1966 CD34+ cells (range 1261–2906).
Conclusion: We found that number of LTC-IC obtained from CD34+ cord blood cells were relatively low in 
numbers when compared to previously reported bone marrow CD34+ cells. This may be due to the lack of 
some transcription and growth factors along with some cytokines and chemokines released by accessory cells 
which are necessary for proliferation of cord blood progenitor/stem cells and it presents an area of interest 
for further studies. (Turk J Hematol 2010; 27: 234-41)
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Özet
Amaç: Ak×m hücre ölçer ve klonojenik yöntemler kullan×m× ile öncül hematolojik hücre fenotiplerinin tan×m-
lanmas×nda çok aüama kaydedilmiü olmas×na raùmen, kemik iliùini yenileyen hücrelerin doùrudan bir yön-
temle tan×mlanmas× henüz mümkün olmamaktad×r. Uzun Dönemli Kültür-Baülatan Hücreler (UDK-BH) in 
vitro fonksiyonel yöntemlerle saptanabilen en öncül insan hematopoietik hücreleridir. 
Yöntem ve Gereçler: Bu araüt×rmada, kordon kan× kök hücrelerinin kemik iliùini yenileyen hücre yeteneùi-
ni ölçümlemek üzere k×s×tl× dilüsyon ile UDK-BH yöntemi uygulanm×üt×r. 
Bulgular: Kordon kan×ndan CD34+ hücrelerin seleksiyonu manyetik boncuklarla baüar× ile gerçekleütiril-
miütir (%73,64±9,12). UDK-BH’lerin 5. haftada ortalama görülme s×kl×ù× 1: 1966 CD34+ hücredir (aral×k: 
1261-2906). Introduction
Although much progress has been made in 
defining primitive hematologic cell phenotypes 
using flow cytometry and clonogenic methods, a 
direct method for study of marrow repopulating 
cells remains elusive. The long-term culture-initiat-
ing cells (LTC-IC) are the most primitive human 
hematopoietic cells detectable by in vitro functional 
assays. The validity of the LTC-IC assay is dependent 
on the existence of a linear relationship between 
the endpoint measured (clonogenic cell output as 
assessed after 5 weeks of culture) and the number 
of LTC-IC in the original test suspension down to 
limiting numbers of LTC-IC. To evaluate cord blood 
stem cells for their repopulating potential, we used 
limiting dilution assay (LDA) for LTC-IC. We believe 
that identification of defined conditions for exten-
sive and rapid amplification of these cells would 
help in analyzing the benefit of these cells for thera-
peutic applications in the future [1-3]. 
LDAs are designed to define an unknown fre-
quency of effector cells in a population. As described 
by Frisan et al. [4], “LDA are dose-response assays 
that allow detection of an all-or-none (positive or 
negative) immunoresponse in each individual cul-
ture within replicates that vary in the number of 
responder cells tested. The frequency of positive 
cultures is not informative because it is never clear 
whether one or more precursors in the culture well 
are giving the positive response. The negative 
response instead demonstrates that there are no 
precursors of a given specificity. Therefore, the 
evaluation of the cell frequency in the original popu-
lation is possible by determining the number of 
cultures that are negative in the experiment”. The 
LDA method for LTC-IC was the method of choice in 
our study to achieve more efficient results.
The type of the feeder layer, cell concentration, 
presence of accessory cells, change of culture 
media, and additional growth factors in the media 
are important for the proliferation of LTC-IC in cul-
ture media [3]. While many different cell lines have 
been published previously as feeder layer [4], it has 
been reported that the murine fibroblast M210-B4 
cell line can support the maintenance of LTC-IC 
from human bone marrow as effectively as stan-
dard human marrow adherent cells [5]. 
Materials and Methods
Sample Collection 
Seventeen cord blood samples were collected 
from healthy mothers delivering in Zeynep Kamil 
Obstetrics Hospital, ústanbul, after their permission 
was obtained. An ethical committee approval 
(021098/90) was provided from Marmara University 
Medical Faculty Ethical Committee. Collections 
were made when placenta was still in utero. No 
samples were collected from mothers with obstet-
ric complications or from those with a history of 
hepatitis C infection or inherited disease. Gender of 
the baby was not considered in the collection and 
evaluation. After the cord was clamped from two 
distal sites, collection was performed with a 50 ml 
syringe containing phosphate-buffered solution-eth-
ylenediaminetetraacetic acid (PBS-EDTA), and 
40-100 ml blood was collected from each cord. 
Samples less than 40 ml were not processed. 
Samples were transported at 18-25°C in specific 
transport boxes. 
Blood Count from the Collected Cord Blood 
Samples
All cord blood samples were counted with auto-
mated cell counter (Coulter AcT cell counter) with-
in 2 hours (h) of sample collection. Cell counts 
were also performed after erythrocyte lysis and 
CD34+cell selection. Cell viability was measured 
with trypan blue dye after each processing. Trypan 
blue stock solution was diluted in a 3:4 ratio with 
isotonic saline. Under the microscope, those cells 
staining blue were counted as dead cells.
Sonuç: CD34+ kordon kan× hücrelerinden elde edilen UDK-BH say×s× daha önce yay×nlarda bildirilen kemik 
iliùi hücreleri deùerlerinden daha düüük düzeyde saptanm×üt×r. Bu bulgunun proliferasyon için gerekli olan 
sinyal transkripsiyon molekülleri, büyüme faktörleri, kemokin ve sitokinlerin aksesuar hücreler taraf×ndan 
sal×narak ortamda olmamas×na baùl× olduùu düüünülmüütür. Bu alanda gelecekte daha çok araüt×rma yap×l-
mas× bilgilerimizin artmas×n× saùlayacakt×r. (Turk J Hematol 2010; 27: 234-41)
Anahtar kelimeler: Kök hücre, kordon kan×, LTC-IC, k×s×tl× dilüsyon, CFU kültürü, akan hücre ölçer
Geliü tarihi: 24 May×s 2010    Kabul tarihi: 19 Aùustos 2010
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For immunophenotyping, cord blood samples 
were labelled with CD45, CD34, HLA-DR, CD38, 
CD71, CD90, and CD135 after blood count. Cell con-
centrations were adjusted to <5x106/ml. All of the 
antibodies and absolute count beads (FlowCount 
Fluorospheres) were obtained from Beckman 
Coulter, Turkey. Since all of the antibodies, except 
CD135, were in conjugated form, direct staining 
method was used. CD135 tube was labelled with 
goat anti mouse-FITC as secondary antibody. 
DHR123 was obtained from Molecular Probes, 
Eugene, OR, USA. Tubes were prepared with the 
following combinations after careful titrations of 
antibodies: IgG1-FITC/IgG1-PE (isotypic control), 
CD45-FITC/CD34-PE, Rhodamine (Rhd)123/CD34-
PE, CD34-FITC (for absolute counts), CD34-FITC/
HLA-DR-PE, CD34-FITC/CD38-PE, CD71-FITC/CD34-
PE, CD90-FITC/CD34-PE, and CD135-FITC/CD34-PE. 
Flow count fluorospheres were used for absolute 
CD34 counts (concentration 1043 beads/+l). After 
labelling with antibodies, tubes were incubated at 
room temperature (18-25°C), in the dark for 15 min-
utes (min); then, a lysing solution (ammonium 
chloride, pH 7.2-7.4) was added. After 10 min of 
incubation, cells were washed twice, and cell fixa-
tion was done with 1% PFA (paraformaldehyde, 
Sigma) in a 1:1 concentration. 
For absolute counts, 100 +l of flow count fluoro-
spheres were vortexed and added to CD34 absolute 
count tubes, and absolute counts were calculated 
using the following formula:
Absolute Count  = Total counted cell number  x  Concentration of flow count 
 
    Total counted fluorospheres  fluorospheres
Immunophenotyping analyses were performed 
with EPICS XL-MCL flow cytometry system 
(Beckman Coulter, USA). Before analysis, Flow 
Check beads were used for checking the laser 
alignment, and Flow Set beads were used for fluo-
rescence calibration and to minimize the day-to-day 
variations. 
For each tube, cytometric measurements were 
made using SS/FS (Side Scatter-Granularity/Forward 
Scatter-Size), FL1 (green fluorescence) and FL2 
(orange fluorescence) parameters. For CD34 counts, 
50,000 nucleated cells were counted in each tube. 
All of the list mode data were recorded and later 
analyzed with System 2.0 software (Beckman 
Coulter, Turkey). 
Selection of CD34+ Cord Blood Cells with 
Magnetic Beads
All of the cell selection and follow-up procedures 
were performed in a clean environment inside the 
laminar air flow hood.
Magnetic separation of the cell suspensions: Mag-
netic separation beads were obtained from Miltenyi, 
Germany.  To prevent non-specific or Fc receptor 
(FcR) binding, 100 +l of FcR blocking reagent was 
added onto cells. For each 108 cells, 100 +l of CD34 
MultiSort MicroBeads were added, mixed well and 
incubated at +4°C for 30 min. The Miltenyi LS col-
umns used for magnetic separation were able to 
select a total of 2 x 109 cells. LS columns, which were 
kept at -20°C the night before the cell processing, 
were taken out of the -20°C 5 min before the selec-
tion time and attached to MidiMACS magnet area, 
and columns were washed three times with ice cold 
PBS containing EDTA and 2% bovine serum albumin 
(PBS-EDTA-BSA buffer) solution. Due to the hydro-
philic structure of the column, buffer solution passed 
through the columns easily and quickly. Cells were 
passed through the column after this priming. 
To eliminate the residual non-CD34 cells, col-
umns were washed with buffer solution twice. 
Then, the column was taken out of the magnet area 
and 5 ml of buffer solution was added to the col-
umn, which was placed over a 15 ml conical tube of 
appropriate size. By applying sudden force to the 
column piston, the CD34+ cells that were attached 
to magnetic beads were pushed into the collection 
tube. The force applied to the column pistol was 
critical for the CD34+ cell yield. A small portion of 
cells were taken for immunophenotypic analysis. 
For disattachment of MACS MultiSort beads, Multi-
Sort Release Reagent (20 +l/ml) was used, and cells 
were incubated at +4°C for 10 min. After cells were 
centrifuged at 400xg, pellet was resuspended to 107 
cells/50 +l. 30 +l MACS MultiSort Stop Reagent was 
added for each 107 cells. Cells were diluted in RPMI-
1640 before cell culture. 
CD34 Immunophenotyping of CD34-Selected 
Samples by Flow Cytometry 
Isotypic control (IgG1-FITC/IgG1-PE), CD34-FITC, 
CD34-PE and CD34-+Rhd123 tubes were labelled 
using the direct method. After incubation at room 
temperature for 15 min, cells were washed with 
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analyzed by flow cytometry (EPICS XL-MCL, Beck-
man Coulter, Ltd), and the results were evaluated 
with System 2.0 software.
Cell Culture and Assays for CD34+ Cells
LTC-IC (Long-Term Culture-Initiating Cells)
Even though there have been many develop-
ments for determination of the precursor and pro-
genitor cells of hematopoietic cells, there is still no 
specific analytical means of determining the bone 
marrow repopulating cells. Cells obtained through 
LTC-IC are the most primitive cells that can be ana-
lyzed by in vitro functional assays. The validity of the 
LTC-IC assays is dependent on the existence of a 
linear relationship between the endpoint measured 
(clonogenic cell output as assessed after 5 weeks of 
culture) and the number of LTC-IC in the original 
test suspension down to limiting numbers of LTC-IC 
[6,7]. We used the limiting dilution method for LTC-
IC in order to evaluate the bone marrow renewal 
capacity of the cord blood CD34+ cells (Figure 1). 
As feeder layer, a murine bone marrow stroma, 
M2-10B4 (ATCC, CRL 1972), known to release the 
necessary cytokines and growth factors, has been 
used [8,9]. M2-10B4 cells were fed with RPMI 1640 
(Sigma, USA) cell culture medium with 10% fetal 
bovine serum (FBS) in cell culture flasks. After they 
became confluent in approximately one week, cells 
were irradiated with 15 Gy in 137Cs, trypsinized, 
washed and diluted in IMDM (Iscove’s Modified 
Dulbecco’s Medium) containing 10% FBS (Sigma), 
10% horse serum (Sigma), and 10-6 M hydrocortisone 
(Sigma). After cell count and adjustment of cell con-
centration, cells were distributed to 96- well plates, 
15,000 - 22,000 cells/well. These feeder layer plates 
were kept ready with change of medium twice a 
week and were used in two weeks. CD34+ cord 
blood cells, selected with MACS magnetic beads, 
were cultured on these M2-10B4 feeder layers with 
six different dilutions [1, 10, 100, 300, 1000, 5000) in 
16 wells for each concentration. Cultures were incu-
bated in a humidified atmosphere containing 5% 
CO2 in air at 37°C. Culture plates were fed with half 
medium changes for five weeks. CAFCs (Cobblestone 
Area Forming Cells) were defined as cell groups of at 
least 15 cells under phase contrast inverted micro-
scope with typical appearance at weeks 5-8. LTC-IC 
absolute counts with LDA were evaluated as 
described previously [10-12]. 
MethoCult GF+ Semi-Solid Culture System
MethoCult obtained from Stem Cell Technologies, 
Canada was used for colony-forming unit (CFU) 
assays. This culture media consists of methyl cellu-
lose, FBS, BSA, 2-mercaptoethanol, L-glutamine, 
recombinant human (rh) stem cell factor, rh granu-
locyte-macrophage colony-stimulating factor 
(GM-CSF), rh interleukin (IL)-3, rhIL-6, rhG-CSF, and 
rhErythropoietin. Cells were seeded in 300 
CD34+cell/ml concentration. Colonies were first 
observed between days 12-15 under inverted micro-
scope and counted on day 14 when the number of 
colonies was at the maximum. Two independent 
scientists counted the colonies on the same day 
and mean values were reported. Groups containing 
more than 40 cells were considered as colonies. 
CFU-GM, BFU-E (Burst Forming Unit-Erythroid) and 
CFU-GEMM (granulocyte, erythroid, monocyte, 
macrophage) colonies were differentiated accord-
ing to the following criteria: CFU-GM colonies were 
observed as transparent, flat and non hemoglobin- 
consisting colonies, and as very dense colonies; 
BFU-E were discriminated easily as dense, with 
color changing from orange to red due to their 
hemoglobin content; CFU-GEMM could be deter-
mined easily, since they contained both erythroid 
and myeloid cells with both transparent and orange-
red hemoglobin-containing cells [12]. 
Results
Immunophenotypic characteristics of the cord 
blood samples are summarized in Table 1. The 
CD45 percentage of the cord blood mononuclear 
cells was lower compared to bone marrow or 
peripheral blood due to the presence of nucleated 
erythrocytes in the analysis area. CD71 was used to 
determine the percentage of nucleated erythro-
cytes and found to be 10.2±1.78%. 
The mononuclear cell content and CD34 values 
before and after selection are summarized in Table 2. 
Mean CD34 percentage before positive selection 
with MACS beads was 1.2±0.26%, and there was a 
purity of 73.64±9.12% after selection. 
CAFCs were obtained after 5 weeks of culture. 
After CAFC was observed, cells from the CAFC-
positive wells were transferred to MethoCult GF+ 
semi-solid cultures to observe the colonies on 
days 14-15. 
Demirel et al.
LTC-IC of CD34-selected cord blood Turk J Hematol 2010; 27: 234-41 237Only 60% of the MethoCult GF+ cultures obtained 
from CAFC of LTC-IC gave rise to HPP-Q (High 
Proliferative Potential-Quiescent) colonies, while all 
cultures had BFU-E, GM and GEMM colonies by day 
14, as shown in Figure 2. LTC-IC numbers calculat-
ed as LTC-IC/CD34+ cells are presented in Table 3.
Discussion
Although the number of articles on cord blood 
LTC-IC are somewhat limited, our LTC-IC/CD34+ 
cell numbers were lower compared to some of the 
published studies [13,14], but results of several 
studies were consistent with ours [15]. There are 
several controversial issues, which will be dis-
cussed in the remainder of this article.
LTC-IC assay with limiting dilution is relatively 
easier than the other LTC-IC assays, since the pre-
prepared murine bone marrow stromal cell line 
plates can be used in five weeks, and counting 
CFUs is easier than counting CAFCs. This method is 
Table 1. Immunophenotypic characteristics of cord blood cells before 
selection 
Immunophenotypic Markers  Positivity (%) +/- SD1
CD34 (Stemness marker)   1.2±0.26
CD45 (Pan leukocyte marker)  84.8±2.0
CD38 (Activation marker, positive on SCs)  57.0±7.45
CD71 (Activation marker, positive on erythroid cells)  10.2±1.78
CD90 (Stem cell marker)  0.4±0.39
HLA-DR (MHC Class II marker)  11.3±1.31
CD135 (FLT3-Stem cell marker)   11.9±3.11
CD45 percentage is less than 90% due to presence of nucleated erythrocytes in 
cord blood
Table 2. MNC and CD34 levels before and after CD34+ cell selection 
with MACS beads
  Before Selection  After Selection
Percentage of CD34  1.2±0.26  73.64±9.12
Mononuclear Cell Count  1.8±0.65  0.19±0.12
(x 106/ml)
Cord Blood Collection
Blood Count 
CD34+ cell selection by beads
CD34+ Cell Analysis by FC 
Observing CAFC by 5th week
Colony count on day 14
Calculation of results
Transfer to semi-solid medium, MethoCult
Inoculation of CD34+ cells with LDA method on 
pre-prepared irradiated murine cell line M210-B4
Thawing M210-B4 cells 
Culture of M210-B4 cells 
Irradiation of M210-B4 cells 
Confluence of cells
Twice/week medium exchange
Half medium change/twice a week
Figure 1. A summary of the LTC-IC by LDA method. FC: Flow cytometry, LDA: Limiting dilution assay, CAFC: Cobblestone area forming cells 
Demirel et al.
LTC-IC of CD34-selected cord blood Turk J Hematol 2010; 27: 234-41 238used as an “ex vivo expansion” assay for CD34+ 
cells. When only the CAFCs were scored, a higher 
frequency of LTC-IC was estimated in cultures utiliz-
ing the M2-10B4 cell line [16]. 
The role of LTC-IC in long-term engraftment is 
unknown; however, they are the most primitive pro-
genitors that can be detected in an in vitro assay. 
Among the cultured LTC-IC, some cells remain qui-
escent and others are thought to be triggered into 
proliferation. Clinical studies have been performed 
with ex vivo expanded cells from autologous stem 
cell harvests; however, it is unknown if the long-
term engraftment was achieved from ex vivo 
expanded cells including LTC-IC or from surviving 
stem cells in patients. 
A recent study reported that type of stromal 
feeder layer used in LTC-IC LDA affects the determi-
nation of LTC-IC frequencies in uncultured cells and 
also has a significant effect on cultures. In their 
study, Nadali et al. [16] noted that proliferative 
capacity of CB LTC-IC can be strongly influenced by 
culture conditions and that the frequency of LTC-IC 
estimated using these cell lines as stromal support 
is not identical. They emphasized that long-term 
Table 3. LTC-IC counts from CD34+ selected cord blood cells (range: 
1261-2906, mean: 1966±808)
Samples LTC-IC/CD34+  cells
1 2705
2 2906
3 2580
4 1649
5 1781
6 1280
7 1649
8 2499
9 1350
10 1261
Mean Value  1966±808
Figure 2. CAFC and CFUs obtained from CD34+ cord blood cells are shown. CAFC were measured at week 5 and then cells were trans-
ferred to MethoCult, a semicellulose commercial media used for CFU assays. CFUs were counted on day 12 (week 7). A. Cobblestone Area 
Forming Cells (CAFCs) after week 5. B. CFU-GEMM: Colony Forming Unit-GranulocyteErythroidMonocyteMacrophage. C. BFU-E: Burst Form-
ing Unit – Erythroid. D. Giemsa-stained BFU-E. E. A HPP-Q (High Proliferative Potential-Quiscent) colony. F. A BFU-E and CFU-GM are seen in 
a nearby area of the petri dish in MethoCult media
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marrow can strongly influence the in vitro behavior 
of LTC-IC and may lead to errors in estimating the 
frequency of LTC-IC. Even though it is easier to grow 
and maintain cell lines such as M2-10B4, one can 
not be sure if they are releasing all of the necessary 
cytokines, chemokines and growth factors. 
Due to use of various cell lines or bone marrow 
stromal cells, there have been diverse outcomes 
from different laboratories worldwide [17-19]. It has 
been published that CD34+ purification is one of 
the prerequisites for successful expansion. Howev-
er, it is also the reason for the lower number of 
colonies counted in this assay, since the cells such 
as monocytes and lymphocytes, which release dif-
ferent growth factors, cytokines and chemokines, 
are not present to help the stem cell proliferation.
The temperature of the LTC-IC was kept at 35°C 
in our study. Some of the earlier studies have used 
37°C for the first three to four days and then 
switched to 33°C, but most of these studies were for 
murine LTC-IC [17]. Podesta et al. [19] published 
that temperature has an effect on colony growth of 
human progenitor cells, and LTC-IC performed at 
37°C gave rise to more colonies than those at 33°C. 
One of the reasons for the lower numbers of colo-
nies in our study could be the temperature. 
Clinical trials of ex vivo expanded cord blood are 
under way in the United States and Europe, using 
CD34+ selected cells expanded in Teflon culture 
bags and non-selected cord blood mononuclear 
cells expanded in bioreactors. These experiments 
are testing different combinations of cytokines to 
determine the optimal dose of cytokines to lead to 
improved stem cell engraftment [20]. 
STAT-5 is a signal tranducer and activator of tran-
scription, involved in self renewal, proliferation and 
apoptosis of hematopoietic cells. Schepers et al. 
[21] performed STAT5 RNAi in sorted cord blood 
cells by lentiviral transduction, and investigated the 
effects of STAT5 downmodulation on normal stem/
progenitor cell compartment. They showed that 
LDAs with cord blood had a 3.9-fold reduction in 
progenitor numbers. Their data indicated that STAT5 
expression is required for the maintenance and 
expansion of primitive hematopoietic stem and pro-
genitor cells, both in normal and leukemic hemato-
poiesis [21]. STAT5 and expression of other tran-
scription factors may also have played a role in the 
lower number of colony counts in our study. 
Even though there has been some progress in 
the standardization of the LTC-IC culture methods, a 
more standardized approach will help us to achieve 
better results for ex vivo expansion of hematopoi-
etic cells. We believe that identification of defined 
conditions for extensive and rapid amplification of 
LTC-IC would help to analyze the benefit of these 
cells for therapeutic applications in the future. We 
now know that standardization of the method with 
human originated feeder layer cells and use of ani-
mal-free medium are necessary to use these cells in 
therapeutic applications. By implementing the LDA 
method for LTC-IC in our laboratory, we have taken 
a step forward for the ex vivo expansion of stem 
cells and will proceed with further research in the 
future with more studies on cell-to-cell contact and 
cytokine/chemokine effect on LTC-IC. 
We also suggest that more information about the 
in vivo scenario can be gained with further insight 
into the use of human cord blood stromal cells or 
HUVEC (human umblical vein endothelial cells) as 
feeder layers and with exploration of in vitro behav-
ior of LTC-IC for CFC production. 
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